
depocyt
Pharmaranks rates Depocyt 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Depocyt (Cytarabine) is a nucleoside metabolic inhibitor used to treat Leukemia, Lymphoma, Meningeal Neoplasms.
Cytarabine · by Pacira Pharms Inc
Available as a generic: Cytarabine
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Cytarabine
- Drug class
- Nucleoside Metabolic Inhibitor
- Form
- Injectable, Liposomal
- Strength
- Cytarabine 10MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- leukemia, lymphoma, meningeal neoplasms
- Manufacturer
- Pacira Pharms Inc
- FDA application
- NDA021041
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Gemcitabine — LiverTox, NCBI Bookshelf (NIH).
May treat (source: NIH RxClass)
Dosage forms
Injectable and Liposomal
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Depocyt treat?
- Depocyt (Cytarabine) may be used to treat leukemia, lymphoma, meningeal neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Depocyt work?
- Depocyt is a nucleoside metabolic inhibitor. Nucleoside metabolic inhibitors are fake DNA building blocks that fast-dividing cancer cells mistake for the real thing. Once inside, they get incorporated into the cell's DNA and also block enzymes such as ribonucleotide reductase, which together halt DNA copying and cause the cancer cell to die.
- How is Depocyt rated?
- pharmaranks gives Depocyt a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Depocyt?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Depocyt. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Depocyt?
- Depocyt is marketed by Pacira Pharms Inc. You can see Pacira Pharms Inc's full profile, rating, and other products on pharmaranks.
- Is Depocyt a brand-name or generic drug?
- Depocyt is a brand-name product with the active ingredient Cytarabine. Lower-cost generic equivalents containing Cytarabine are available — ask your pharmacist.
- Is Depocyt available over the counter?
- No. Depocyt is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Depocyt come in?
- Depocyt is currently marketed as injectable and liposomal, per the FDA's National Drug Code Directory.
- What class of drug is Depocyt?
- Depocyt is classified as nucleoside metabolic inhibitor, per the FDA's Established Pharmacologic Class.
- Is Depocyt FDA-registered?
- Depocyt is on record with the U.S. FDA under application number NDA021041. You can verify this on its official FDA label.
- Has Depocyt been recalled by the FDA?
- Depocyt has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Depocyt safe?
- There's no single safe-or-not verdict. pharmaranks gives Depocyt a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cytarabine
Cytarabine
tolak
Fluorouracil
azacitidine
Azacitidine
arranon
Nelarabine
capecitabine
Capecitabine
decitabine
Decitabine
Compare Depocyt head-to-head
More nucleoside metabolic inhibitor drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
depocyt
70/100